Mgr. Karla Plevová, Ph.D.
Head of the research group, Karla Plevová Research Group: Genomics of Immune Cells
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Office: bldg. E35/258
Kamenice 753/5
625 00 Brno
Phone: | +420 532 23 4396 |
---|---|
E‑mail: | |
Web: | https://genomika.med.muni.cz/research/research-groups/karla-plevova-group/about-us |
social and academic networks: |
---|
Total number of publications: 354
2021
-
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL
Blood, year: 2021, volume: 137, edition: 10, DOI
-
Higher-order immunoglobulin repertoire restrictions in CLL: the illustrative case of stereotyped subsets 2 and 169
Blood, year: 2021, volume: 137, edition: 14, DOI
-
Chromothripsis in Chronic Lymphocytic Leukemia: A Driving Force of Genome Instability
Frontiers in Oncology, year: 2021, volume: 11, edition: November 2021, DOI
-
Identification of Clinically Relevant Subgroups of Chronic Lymphocytic Leukemia Through Discovery of Abnormal Molecular Pathways
Frontiers in Genetics, year: 2021, volume: 12, edition: JUN, DOI
-
Klinický dopad a evoluce minoritních TP53-mutovaných klonů v kontextu různých terapeutických režimů u CLL.
Year: 2021, type: Conference abstract
-
Klonální evoluce CLL – význam BCR receptoru a abnormalit genu TP53.
Year: 2021, type: Conference abstract
-
Klonální evoluce CLL podmíněná léčbou: analýza pomocí celoexomového sekvenování.
Year: 2021, type: Conference abstract
-
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options
Blood, year: 2021, volume: 138, edition: 25, DOI
-
LYmphoid NeXt-Generation Sequencing (LYNX) Panel A Comprehensive Capture-Based Sequencing Tool for the Analysis of Prognostic and Predictive Markers in Lymphoid Malignancies
The journal of molecular diagnostics., year: 2021, volume: 23, edition: 8, DOI
-
LYNX (Lymphoid next-generation sequencing): NGS panel a bioinformatic tool for integrative analysis of prognostic and predictive markers in B-cell malignancies.
Year: 2021, type: Conference abstract